ResearcherPancreatic Cancer Action NetworkActive in the last 2 years
Lola Rahib
Matched on ORCID iD 0000-0003-3928-3880; OpenAlex author ID A5055833569. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 13
- Factors Driving Pancreatic Cancer Survival Rates. Co-author DOI 10.1097/mpa.0000000000002489↗
- Pre-Diagnosis Pain in Patients With Pancreatic Cancer Signals the Need for Aggressive Symptom Management. Co-author DOI 10.1093/oncolo/oyad153↗
- Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Co-author DOI 10.1053/j.gastro.2021.09.022↗
- Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.09.043↗
- Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor … Co-author DOI 10.1016/s1470-2045(20)30074-7↗
- Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients. Last author DOI 10.1097/mpa.0000000000001330↗
- Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program. Co-author DOI 10.1200/po.19.00115↗
- Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retro… Co-author DOI 10.1007/s11523-018-0572-3↗
- Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer. Co-author DOI 10.1080/15384047.2016.1210743↗
- Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. Co-author DOI 10.1158/1078-0432.ccr-18-0531↗
- A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Kno… Co-author DOI 10.18632/oncotarget.13225↗
- Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review. Co-author DOI 10.1001/jamaoncol.2016.0585↗
- Pancreatic cancer clinical trials and accrual in the United States. Co-author DOI 10.1200/jco.2013.49.4823↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lynn McCormick Matrisian · 9 shared papers, 2013–2023 · strength 0.80
- Paper Pre-Diagnosis Pain in Patients With Pancreatic Cancer Signals the Need for Aggressive Symptom Management. DOI 10.1093/oncolo/oyad153↗
- Paper Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Pat… DOI 10.1097/mpa.0000000000001330↗
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Barbara J. Kenner · 1 shared paper, 2025 · strength 0.42
- Tara B. Coffin · 1 shared paper, 2025 · strength 0.42
- Jonathan Robert Brody · 5 shared papers, 2017–2020 · strength 0.36
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Paper Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results Fro… DOI 10.1200/po.19.00115↗
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- Michael Jon Pishvaian · 5 shared papers, 2017–2020 · strength 0.36
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Paper Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results Fro… DOI 10.1200/po.19.00115↗
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- Andrew Eugene Hendifar · 4 shared papers, 2017–2020 · strength 0.29
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Paper Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results Fro… DOI 10.1200/po.19.00115↗
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- Vincent M. Chung · 4 shared papers, 2017–2020 · strength 0.29
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Paper Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results Fro… DOI 10.1200/po.19.00115↗
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- William Arthur Hoos · 4 shared papers, 2013–2019 · strength 0.28
- Paper Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Pat… DOI 10.1097/mpa.0000000000001330↗
- Paper Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients … DOI 10.1007/s11523-018-0572-3↗
- Paper A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic … DOI 10.18632/oncotarget.13225↗
- Davendra P. S. Sohal · 3 shared papers, 2018–2020 · strength 0.24
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Paper Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results Fro… DOI 10.1200/po.19.00115↗
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- Emanuel F. Petricoin · 3 shared papers, 2018–2020 · strength 0.24
- Paper Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retros… DOI 10.1016/s1470-2045(20)30074-7↗
- Paper Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results Fro… DOI 10.1200/po.19.00115↗
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- Terry Ann McNearney · 1 shared paper, 2023 · strength 0.22
- Vincent J. Picozzi · 2 shared papers, 2017–2018 · strength 0.12
- Paper Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. DOI 10.1158/1078-0432.ccr-18-0531↗
- Paper A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic … DOI 10.18632/oncotarget.13225↗
- Jamie S. Barkin · 1 shared paper, 2019 · strength 0.10
- Jodie A. Barkin · 1 shared paper, 2019 · strength 0.10
- Vaibhav Sahai · 1 shared paper, 2020 · strength 0.09
- Timothy R. Donahue · 1 shared paper, 2018 · strength 0.09
- William H. Isacoff · 1 shared paper, 2018 · strength 0.09
- Howard A. Reber · 1 shared paper, 2018 · strength 0.09
- Oscar Joe Hines · 1 shared paper, 2018 · strength 0.09
- Jordan D. Berlin · 1 shared paper, 2016 · strength 0.08
- Cinthya S. Yabar · 1 shared paper, 2018 · strength 0.06
- Mahsa Zarei · 1 shared paper, 2018 · strength 0.06
- Jordan Michael Winter · 1 shared paper, 2018 · strength 0.06
- Charles J. Yeo · 1 shared paper, 2018 · strength 0.06
- Wei Jiang · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.